NHS
Scotland recommends Roche’s Perjeta for HER2+ metastatic breast cancer
January 15, 2019Manufacturing and Production, Sales and Marketing Breast cancer; Roche; Scotland, NHS, Perjeta, UK, pharma
Breast cancer patients in Scotland are set to receive an additional treatment option, as the Scottish Medicines Consortium announces its …
Government appoints health minister from firm trying to win NHS contracts
January 14, 2019Sales and Marketing NHS, corruption, digital, government, online, politics
The British Government has come under fire over the appointment of former Tory MP, Nicola Blackwood, as a junior minister …
NICE recommends AstraZeneca’s Fasenra as third treatment option for severe asthma
January 4, 2019Medical Communications, Sales and Marketing AstraZeneca, Fasenra, NHS, NICE, UK, asthma, pharma
It’s good news for both asthma patients and AstraZeneca after UK drug watchdog NICE saw fit to recommend the drugmaker’s …
NHS spends £26 million on consultancy
December 18, 2018Manufacturing and Production BMA, Consultancy, Jobs, NHS, health
Private consultancy firms were paid at least £26 million as part of a reorganisation of the NHS, in what has …
NHS overcrowding leads to ambulances being turned away
December 17, 2018Sales and Marketing Hopsitals, NHS, UK, health, politics
NHS England’s first weekly report of the winter has revealed that 95% of hospital beds are occupied, while anything above …
‘Significant’ health outcomes gap still exists in Scotland
December 14, 2018Medical Communications NHS, Scotland, UK, health, inequality
There is a significant gap in health outcomes between the most and least deprived areas of Scotland, a Scottish government …
Data reveals November’s performance was worst on record for NHS
December 14, 2018Medical Communications NHS, NHS England, UK, funding, investment, wait times
November saw the worst A&E performance on record, according to data released by NHS England. The number of patients who …
Government choose England top pharmacist to address overprescribing and polypharmacy
December 13, 2018Medical Communications, Research and Development England, Matt Hancock, NHS, medicine, pharma
England’s chief pharmaceutical officer Dr Keith Ridge has been chosen to look into ‘problematic’ overprescribing in the NHS. The move …
Health Secretary Matt Hancock says government may charter flights to deliver medicines in case of no-deal Brexit
December 7, 2018Medical Communications Matt Hancock, NHS, UK, brexit, no-deal
British health secretary Matt Hancock has said the government is working out ways through which they could charter flights in …
NICE give go-ahead to Gilead’s Yescarta for adults with lymphoma
December 7, 2018Medical Communications Cancer, Cost, Gilead, NHS, NICE, Yescarta, access
The NHS cost effectiveness body NICE has approved Gilead’s Yescarta for treatment of come adults with lymphoma. Gilead’s treatment will …
Cancer drug access for NHS patients is slowing, ICR reports
December 4, 2018Manufacturing and Production, Research and Development, Sales and Marketing Cancer, ICR, Institute of Cancer Research, NHS, NICE, UK, pharma
A new report from the Institute of Cancer Research (ICR) has indicated that NHS patients in the UK are suffering …
Top Ten most popular articles on Pharmafile.com this week
November 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, Immuno Biotech, NHS, Roche, autism, biosimilars, pharma, top ten
We’ve come to the end of November, and with only one month of the year left to go, the industry …
UK cervical cancer screening rates fall to 21-year low
November 28, 2018Medical Communications, Research and Development Cancer, NHS, UK, cervical cancer, pharma
A report by NHS Digital has revealed that cervical cancer screening coverage has fallen to 71.4%, down from 72% in …
NHS to save £300 million by switching to Humira biosimilars
November 27, 2018Manufacturing and Production, Sales and Marketing AbbVie, Humira, Mylan, NHS, Sandoz, adalimumab, biosimilars, pharrma
NHS England has announced that the health service is set to save £300 million by switching to biosimilar versions of …
NHS hospitals paying 167% more for drugs since 2010/11
November 23, 2018Medical Communications Cost, NHS, UK, hospitals, pricing
Medicines are costing the NHS more than 50% more than a decade ago, while hospitals are paying more than twice …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
